Stockscreener 앱 받기
0.68%
시장 영업 전:
Pfizer Inc 주식(PFE)의 최신 뉴스
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
BMO Capital Maintains a Buy on Pfizer Inc (PFE), Keeps the PT - Yahoo Finance
Pfizer (PFE) Doubles Down on Obesity Market—But Will It Pay Off? - MSN
Pfizer Inc. (PFE): A Bull Case Theory - Yahoo Finance
Why Pfizer's Post-COVID Future Looks Brighter Than Ever - Yahoo Finance
Down 55%, Should You Buy the Dip on Pfizer? - AOL.com
Sonora Investment Management Group LLC Has $10.90 Million Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Acquired by Fort Washington Investment Advisors Inc. OH - MarketBeat
Stockman Wealth Management Inc. Buys 30,849 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer’s Bold GLP‑1 Comeback, Dividend Safe For Now (NYSE:PFE) - Seeking Alpha
Kendall Capital Management Makes New $422,000 Investment in Pfizer Inc. $PFE - MarketBeat
Kathmere Capital Management LLC Purchases 16,724 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer: A Reluctant Upgrade To Hold (NYSE:PFE) - Seeking Alpha
How Pfizer Inc. (PFE) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Should You Reconsider Pfizer as Shares Fall After Latest Drug Pipeline Setback? - simplywall.st
Pfizer (PFE) to Acquire Metsera in $4.9 Billion Deal - GuruFocus
Key facts: President Trump plans a 100% tariff on branded drugs, including Pfizer's, unless firms set up U.S. manufacturing plants to protect local producers from foreign imports. - TradingView
Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more (PFE:NYSE) - Seeking Alpha
Is Pfizer Stock a Buy After Its $5 Billion GLP-1 Bet? - The Globe and Mail
Pfizer’s GLP-1 acquisition; Trump’s tariff threat; Scholar Rock gets a CRL; and more - Endpoints News
State of Alaska Department of Revenue Has $18.70 Million Holdings in Pfizer Inc. $PFE - MarketBeat
Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why. - Barron's
Pfizer is Locking in New Growth Through a New Acquisition - MarketBeat
Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock? - MSN
Pfizer Faces Court Over Depo-Provera Brain Tumor Claims - Benzinga
Pfizer just made a quiet move that could rewrite the obesity drug race - TheStreet
Trump Pharma Plan Looks Like Reprieve for Many Drugmakers - Yahoo Finance
Jim Cramer Discusses Sentiment Surrounding Pfizer (PFE) - MSN
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict - ts2.tech
Dakota Wealth Management Reduces Stock Holdings in Pfizer Inc. $PFE - MarketBeat
Maridea Wealth Management LLC Has $233,000 Stake in Pfizer Inc. $PFE - MarketBeat
14,681 Shares in Pfizer Inc. $PFE Acquired by FCG Investment Co - MarketBeat
New Insight Wealth Advisors Acquires 31,696 Shares of Pfizer Inc. $PFE - MarketBeat
Meyer Handelman Co. Sells 11,350 Shares of Pfizer Inc. $PFE - MarketBeat
Eli Lilly, Merck, Pfizer Stocks Rise After Trump Unveils Pharma Tariffs - The Wall Street Journal
Pfizer (PFE) Dips More Than Broader Market: What You Should Know - sharewise.com
Precision Trading with Pfizer Inc. (PFE) Risk Zones - news.stocktradersdaily.com
Pfizer (NYSE:PFE) Trading Down 2%Should You Sell? - MarketBeat
Pfizer: Buy The Pharma Giant Following The Metsera Deal (NYSE:PFE) - Seeking Alpha
Rx Rundown: Pfizer, Genetix Biotherapeutics, Sanofi and more - Medical Marketing and Media
5.6x Brain Tumor Risk: Pfizer's Depo-Provera Contraceptive Faces 1,300 Lawsuits as New Studies Confirm Danger - Stock Titan
Hearing Against Pfizer Set For 29 September In Contraceptive ‘Depo-Provera’ Multidistrict Litigation Overseen By Levin Papantonio - The Joplin Globe
Pfizer: Invest For The Yield, Not The Weight-Loss Drug Chase (NYSE:PFE) - Seeking Alpha
Pfizer-backed biotech readies expansion after trial success - The Business Journals
Pfizer, BioNTech Challenge GSK Patents Over Vaccine Tech - Law360
Can a multibillion-dollar deal put Pfizer in the obesity big leagues? - PharmaVoice
November 7th Options Now Available For Pfizer (PFE) - Nasdaq
Does This Acquisition Make Pfizer Stock a Great Buy? - Nasdaq
Geriatric Medicines Market Set for Dynamic Growth with Key - openPR.com
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025 - BioSpace
Pfizer to showcase cancer drug data at ESMO Congress 2025 By Investing.com - Investing.com Canada
Essex Financial Services Inc. Purchases 29,086 Shares of Pfizer Inc. $PFE - MarketBeat
Ruffer LLP Sells 792,785 Shares of Pfizer Inc. $PFE - MarketBeat
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Decreases Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer to showcase cancer drug data at ESMO Congress 2025 - Investing.com
Pfizer Tries to Fatten Its Profits With Weight Loss Drugs - Investing.com
Pfizer Inc. $PFE Shares Purchased by Penn Davis Mcfarland Inc. - MarketBeat
Xcel Wealth Management LLC Reduces Stock Position in Pfizer Inc. $PFE - MarketBeat
Santori & Peters Inc. Purchases 11,000 Shares of Pfizer Inc. $PFE - MarketBeat
1.00%
0.77%
자본화:
|
볼륨(24시간):